Abstract
Background
Prostate tumour overexpressed 1, PTOV1, was recently identified as a novel gene and protein during a differential display screening for genes overexpressed in prostate cancer (PCa). It has been suggested that overexpression of PTOV1 can contribute to the proliferative status of prostate tumour cells and thus to their biological behaviour.
Methods
PTOV1 and Ki67 were immunohistochemically evaluated in PCa, atypical adenomatous hyperplasia (AAH), high-grade prostatic intraepithelial neoplasia (HGPIN), and normal-looking epithelium (NEp) of the transition zone (TZ) in 40 radical prostatectomies with pT2a Gleason score 6 PCa (20 with AAH and 20 with HGPIN) and in 10 simple prostatectomies (SPs) (5 with AAH and 5 with HGPIN). The aim was to evaluate PTOV1 protein expression as a marker for tumor development and progression from AAH to PCa.
Results
The proportions of PTOV1 and Ki67 positive cells increased from NEp through AAH and HGPIN to PCa. In particular, the mean Hscore of PTOV1 expression in AAH was 110.90, i.e., close to three times that of NEp (40.76), similar to that of HGPIN (105.61) and lower than that of PCa (137.03). The mean values in AAH and HGPIN associated with cancer in the RPs were slightly higher than in the SPs.
Conclusion
Our findings related to PTOV1 expression in AAH, similar to those in HGPIN, provide additional evidence linking AAH to prostatic adenocarcinoma.
Similar content being viewed by others
References
D.G. Bostwick, F. Algaba, M.B. Amin, A. Ayala, J. Eble, N. Goldstein, B. Helpap, P. Humphrey, D. Grignon, E.C. Jones, Consensus statement on terminology: recommendation to use atypical adenomatous hyperplasia in place of adenosis of the prostate. Am J Surg Pathol 18, 1069–1070 (1994)
D.G. Bostwick, L. Cheng, Overdiagnosis of prostatic adenocarcinoma. Semin Urol Oncol 17, 199–205 (1999)
D.G. Bostwick, J. Qian, Atypical adenomatous hyperplasia of the prostate. Relationship with carcinoma in 217 whole-mount radical prostatectomies. Am J Surg Pathol 19, 506–518 (1995)
D.G. Bostwick, J. Srigley, D. Grignon, J. Maksem, P. Humphrey, T.H. van der Kwast, D. Bose, J. Harrison, R.H. Young, Atypical adenomatous hyperplasia of the prostate: morphologic criteria for its distinction from well-differentiated carcinoma. Hum Pathol 24, 819–832 (1993)
J.I. Epstein, Adenosis (atypical adenomatous hyperplasia): histopathology and relationship to carcinoma. Pathol Res Pract 191, 888–898 (1995)
P.B. Gaudin, J.I. Epstein, Adenosis of the prostate. Histologic features in transurethral resection specimens. Am J Surg Pathol 18, 863–870 (1994)
A. Lopez-Beltran, J. Qian, R. Montironi, R.J. Luque, D.G. Bostwick, Atypical adenomatous hyperplasia (adenosis) of the prostate: DNA ploidy analysis and immunophenotype. Int J Surg Pathol 13, 167–173 (2005)
R. Montironi, P.H. Bartels, P.W. Hamilton, D. Thompson, Atypical adenomatous hyperplasia (adenosis) of the prostate: development of a Bayesian belief network for its distinction from well-differentiated adenocarcinoma. Hum Pathol 27, 396–407 (1996)
L. Cheng, A. Shan, J.C. Cheville, J. Qian, D.G. Bostwick, Atypical adenomatous hyperplasia of the prostate: a premalignant lesion? Cancer Res 58, 389–391 (1998)
J.A. Doll, X. Zhu, J. Furman, Z. Kaleem, C. Torres, P.A. Humphrey, H. Donis-Keller, Genetic analysis of prostatic atypical adenomatous hyperplasia (adenosis). Am J Pathol 155, 967–971 (1999)
C. Zhang, R. Montironi, G.T. MacLennan, A. Lopez-Beltran, Y. Li, P.H. Tan, M. Wang, S. Zhang, K.A. Iczkowski, L. Cheng, Is atypical adenomatous hyperplasia of the prostate a precursor lesion? Prostate 71, 1746–1751 (2011)
P. Benedit, R. Paciucci, T.M. Thomson, M. Valeri, M. Nadal, C. Càceres, I. de Torres, X. Estivill, J.J. Lozano, J. Morote, J. Reventós, PTOV1, a novel protein overexpressed in prostate cancer containing a new class of protein homology blocks. Oncogene 20, 1455–1464 (2001)
S. Fernandez, J.L. Mosquera, L. Alaña, A. Sanchez-Pla, J. Morote, S. Ramón, Y. Cajal, J. Reventós, I. de Torres, R. Paciucci, PTOV1 is overexpressed in human high grade malignant tumors. Virchows Arch 458, 323–330 (2011)
J. Xu, J.A. Stolk, X. Zhang, S.J. Silva, R.L. Houghton, M. Matsumura, T.S. Vedvick, K.B. Leslie, R. Badaro, S.G. Reed, Identification of differentially expressed genes in human prostate cancer using subtraction and microarray. Cancer Res 60, 1677–1682 (2000)
A. Santinelli, R. Mazzucchelli, F. Barbisan, A. Lopez-Beltran, L. Cheng, M. Scarpelli, R. Montironi, alpha-Methylacyl coenzyme A racemase, Ki-67, and topoisomerase IIalpha in cystoprostatectomies with incidental prostate cancer. Am J Clin Pathol 128(657–666) (2007)
R. Mazzucchelli, F. Barbisan, A. Santinelli, A. Lopez-Beltran, L. Cheng, M. Scarpelli, R. Montironi, Immunohistochemical expression of prostate tumor overexpressed 1 in cystoprostatectomies with incidental and insignificant prostate cancer Further evidence for field effect in prostatic carcinogenesis. Hum Pathol 42, 1931–1936 (2011)
J.R. Srigley, Benign mimickers of prostatic adenocarcinoma. Mod Pathol 17, 328–348 (2004)
P.N. Brawn, Adenosis of the prostate: a dysplastic lesion that can be confused with prostate adenocarcinoma. Cancer 49, 826–833 (1982)
B. Helpap, Cell kinetic studies on prostatic intraepithelial neoplasia (PIN) and atypical adenomatous hyperplasia (AAH) of the prostate. Pathol Res Pract 191, 904–907 (1995)
N.S. Goldstein, J. Qian, D.G. Bostwick, Mucin expression in atypical adenomatous hyperplasia of the prostate. Hum Pathol 26, 887–891 (1995)
J. Morote, S. Fernández, L. Alaña, C. Iglesias, J. Planas, J. Reventós, S. Ramón Y Cajal, R. Paciucci, I.M. de Torres, PTOV1 expression predicts prostate cancer in men with isolated high-grade prostatic intraepithelial neoplasia in needle biopsy. Clin Cancer Res 14, 2617–2622 (2008)
A. Santamaría, P.L. Fernández, X. Farré, P. Benedit, J. Reventós, J. Morote, R. Paciucci, T.M. Thomson, PTOV-1, a novel protein overexpressed in prostate cancer, shuttles between the cytoplasm and the nucleus and promotes entry into the S phase of the cell division cycle. Am J Pathol 162, 897–905 (2003)
A. Santamaría, E. Castellanos, V. Gómez, P. Benedit, J. Renau-Piqueras, J. Morote, J. Reventós, T.M. Thomson, R. Paciucci, PTOV1 enables the nuclear translocation and mitogenic activity of flotillin-1, a major protein of lipid rafts. Mol Cell Biol 25, 1900–1911 (2005)
M. Scarpelli, R. Mazzucchelli, F. Barbisan, A. Santinelli, A. Lopez-Beltran, L. Cheng, R. Montironi, Is there a role for prostate tumour overexpressed-1 in the diagnosis of HGPIN and of prostatic adenocarcinoma? A comparison with alpha-methylacyl CoA racemase. Int J Immunopathol Pharmacol 25, 67–74 (2012)
X.J. Yang, C.L. Wu, B.A. Woda, K. Dresser, M. Tretiakova, G.R. Fanger, Z. Jiang, Expression of alpha-Methylacyl-CoA racemase (P504S) in atypical adenomatous hyperplasia of the prostate. Am J Surg Pathol 26, 921–925 (2002)
Acknowledgements
This report was supported by grants from the Polytechnic University of the Marche Region (Ancona), Italy (MS and RM). The content of this paper is solely the responsibility of the authors and does not necessarily represent the official views of the Polytechnic University of the Marche Region (Ancona, Italy).
Author information
Authors and Affiliations
Corresponding author
Additional information
Roberta Mazzucchelli and Marina Scarpelli contributed equally to this paper.
Rights and permissions
About this article
Cite this article
Mazzucchelli, R., Scarpelli, M., Barbisan, F. et al. Immunohistochemical expression of prostate tumour overexpressed 1 (PTOV1) in atypical adenomatous hyperplasia (AAH) of the prostate. Cell Oncol. 36, 37–42 (2013). https://doi.org/10.1007/s13402-012-0111-7
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13402-012-0111-7